Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life.

Fiorenzo Santoleri,Elena Ranucci,Gaetano La Barba,Irene Colasanto,M Scaldaferri,Francesco Cattel,Francesca Federici,Chiara Rossi,Katiuscia Di Biagio,Anna Rita Scortechini,Felice Musicco,Giancarlo Torquati,Angela Frazzetto,Antonietta Vozza,Caterina de Rosa,Rosaria Lanzillo,Maria Monteverde,Luigia Luciano,Fabrizio Pane,Arianna Pasquazi,Maria Grazia Celeste,Maria Cantonetti,Luca Franceschini,Manuela Rizzo,Alberto Costantini

Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life.

2021

The use of dasatinib and nilotinib in the treatment of patients with chronic myeloid leukemia represents a valid therapeutic option for patients resistant or intolerant to imatinib. In this multice...

Keywords:

Internal medicine
Oncology
in real life
multicenter study
Imatinib
Persistence (computer science)
Nilotinib
Myeloid leukemia
Medicine
Dasatinib
chronic myeloid leukaemia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations